Direct accesses

  • Go to main menu
  • Go to main content
Menu
GenSight GenSight
Search the site
  • Contact
  • Careers
  • You are viewing the website in English en
  • fr
Search the site
  • Whowe are
    • Company
    • Leadership
    • Collaborations
  • Diseaseswe target
    • Diseases we target
    • Leber Hereditary Optic Neuropathy (LHON)
    • Retinitis Pigmentosa (RP)
    • Geographic Atrophy in Dry-AMD
  • Ourtechnologies
    • Technologies we are applying
    • Gene Therapy
    • Mitochondrial Targeting Sequence (MTS)
    • Optogenetics
    • Clinical development Summary
  • Investors
    • Company Overview
    • Financial press releases
    • Investor Newsletters
    • Events & presentations
    • Stock information & Financial agenda
    • Governance
    • Documentation
  • Media

Documentation

  • Home >
  • Investors & media >
  • Documentation
23 April 2025
General Assembly, General meetings

OCA Report Open in new window

23 April 2025
General Assembly, General meetings

Rapport des commissaires aux comptes sur les états financiers consolidés 2024 en normes IFRS Open in new window

23 April 2025
General Assembly, General meetings

Rapport complémentaire Opération de Novembre 2024 Open in new window

23 April 2025
General Assembly, General meetings

BSA Report Open in new window

23 April 2025
General Assembly, General meetings

Rapport spécial des commissaires aux comptes sur les conventions réglementées 2024 Open in new window

23 April 2025
General Assembly, General meetings

Rapport complémentaire Placement prive Mai 2024 Open in new window

23 April 2025
General Assembly, General meetings

Rapport complémentaire catégorie de personne MAI 2024 Open in new window

23 April 2025
General Assembly, General meetings

Proxy voting form – AGM 2025 Open in new window

23 April 2025
General Assembly, General meetings

Rapport complémentaire opération de Decembre 2024 Open in new window

23 April 2025
General Assembly, General meetings

Shares and voting rights statement – 2025 General Meeting Open in new window

  • View previous 9 articles
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • …
  • 23
  • View next 9 articles
© 2025 Gensight Biologics
  • Terms of use
  • Sitemap
  • Contact
  • Credits
  • Cookies management
Go back to the page of the page